MedicGo
Cyclosporine as a preferred calcineurin inhibitor in renal allograft recipients with COVID-19 infection.
Metadata
Journalkidney international8.945Date
2020 Jun 04
4 months ago
Type
Comment
Letter
Volume
2020-08 / 98 : 507-508
Author
Kemmner S 1, Guba MO 2, Schönermarck U 3, Stangl M 2, Fischereder M 3
Affiliation
  • 2. Department of General, Visceral, and Transplant Surgery, University Hospital Munich, Ludwig-Maximilians University (LMU), Munich, Germany.
  • 3. Renal Division, Department of Internal Medicine IV, University Hospital Munich, Ludwig-Maximilians University (LMU), Munich, Germany.
Doi
PMIDMESH
Betacoronavirus
Calcineurin
Calcineurin Inhibitors
Coronavirus Infections
Cyclosporine
Humans
Kidney Transplantation
Pandemics
Pneumonia
Pneumonia, Viral
Severe Acute Respiratory Syndrome
Fav
Like
Download
Share
Export
Cite
8.9
Kidney Intkidney international
Metadata
LocationUnited States
FromELSEVIER SCIENCE INC

No Data

© 2017 - 2020 Medicgo
Powered by some medical students